fibroblast growth factor receptor 1
| UniProt | Protein Name |
|---|---|
| A0A0S2Z3Q6 |
|
| P11362 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of transcription by RNA polymerase II | ||
| MAPK cascade | ||
| skeletal system development | ||
| angiogenesis | ||
| ureteric bud development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| postsynapse | ||
| glutamatergic synapse |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein tyrosine kinase activity | ||
| GPI-linked ephrin receptor activity | ||
| transmembrane-ephrin receptor activity | ||
| epidermal growth factor receptor activity | ||
| fibroblast growth factor receptor activity |
| Gene Ontology |
|---|
| ATP binding |
| fibroblast growth factor receptor activity |
| nucleotide binding |
| transmembrane receptor protein tyrosine kinase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060597 | atypical chronic myeloid leukemia, BCR-ABL1 negative | |
| DOID:0070004 | myeloid neoplasm | |
| DOID:0081312 | T-cell non-Hodgkin lymphoma | |
| DOID:0090078 | hypogonadotropic hypogonadism 7 with or without anosmia | |
| DOID:0090083 | hypogonadotropic hypogonadism 2 with or without anosmia | |
| DOID:0111337 | Jackson-Weiss syndrome | |
| DOID:0111532 | osteoglophonic dysplasia | |
| DOID:12960 | acrocephalosyndactylia | |
| DOID:14705 | Pfeiffer syndrome | |
| DOID:3908 | lung non-small cell carcinoma |
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 116435512 | CORMO12932 | ||
| 116821412 | CHEAB08451 | ||
| 117021283 | RHIFE03936 | ||
| 118313772 | SCOMX32312 | ||
| 118887767 | BALMU31288 | ||
| 122217613 | PANLE26957 | ||
| 123780346 | URSAM23882 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025